找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202

[复制链接]
查看: 39651|回复: 57
发表于 2025-3-21 17:26:38 | 显示全部楼层 |阅读模式
书目名称Diagnoses Without Names
副标题Challenges for Medic
编辑Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya
视频video
概述Examines the circumstances in which diagnosis names are unassignable.Explores how different stakeholders used diagnosis names for different purposes.Advocates for including diagnostic uncertainty in p
图书封面Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202
描述Doctors, patients, investigators, administrators, and policymakers who assign diagnoses assume three elements: the name describes an entity with conceptual or evidentiary boundaries, the person setting the name has a high degree of certainty, and the name has a consensus definition. This book challenges this practice and offers an alternative to assigning diagnoses: quantitating diagnostic uncertainty in personal and public medical plans..This book offers the stakeholders‘ views participating in a workshop, sponsored by the Barbara Volcker Center/Hospital for Special Surgery, taking place in April 2020, about uncertain diagnoses. Chapters examine the circumstances in which diagnosis names are "unassignable", either because patients do not fit within diagnostic "boxes" or because health abnormalities evolve and change over time. In addition, the book deconstructs the processes of diagnosis and explores how different stakeholders used diagnosis names for various purposes. In examining pertinent questions, the book offers a roadmap to achieving consensus definitions or including measures of uncertainty in personal care, research, and policy..Diagnoses Without Names: Challenges for Med
出版日期Book 2022
关键词Clinical trials and diagnostic uncertainty; Diagnoses without names; Diagnostic certainty; Diagnostic t
版次1
doihttps://doi.org/10.1007/978-3-031-04935-4
isbn_softcover978-3-031-04934-7
isbn_ebook978-3-031-04935-4
copyrightSpringer Nature Switzerland AG 2022
The information of publication is updating

书目名称Diagnoses Without Names影响因子(影响力)




书目名称Diagnoses Without Names影响因子(影响力)学科排名




书目名称Diagnoses Without Names网络公开度




书目名称Diagnoses Without Names网络公开度学科排名




书目名称Diagnoses Without Names被引频次




书目名称Diagnoses Without Names被引频次学科排名




书目名称Diagnoses Without Names年度引用




书目名称Diagnoses Without Names年度引用学科排名




书目名称Diagnoses Without Names读者反馈




书目名称Diagnoses Without Names读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:56:00 | 显示全部楼层
A Pragmatic Approach to Diagnostic Categorization. Sometimes pragmatic choices need to be made between candidate diagnostic frameworks. Various kinds of diagnostic difficulty are explored, including differences between research and clinical diagnostic categories, “not otherwise specified” categories, and stigmatized diagnoses.
发表于 2025-3-22 03:46:53 | 显示全部楼层
发表于 2025-3-22 06:12:15 | 显示全部楼层
Toward Molecular Diagnoses for Autoimmune Rheumatic Diseasesdisorders exhibit extensive clinical and immunologic heterogeneity, and many patients present with evidence of rheumatic diseases but do not fulfill classification criteria, resulting in patient uncertainty and delays in diagnosis and treatment. Several studies have defined distinct molecular signat
发表于 2025-3-22 09:07:46 | 显示全部楼层
发表于 2025-3-22 14:06:04 | 显示全部楼层
Confronting the Inevitability of Diagnostic Uncertainty Across Multiple Legal Domainsd future course of a particular patient’s ailment posed no great difficulties. As external scrutiny of patient management choices has become commonplace, diagnostic uncertainty poses greater challenges. Although a temptation may exist to visit much of the blame on legal institutions, agencies and co
发表于 2025-3-22 17:16:02 | 显示全部楼层
发表于 2025-3-22 22:31:22 | 显示全部楼层
发表于 2025-3-23 03:47:39 | 显示全部楼层
The Impact of Antinuclear Antibody Testing on the Naming and Misnaming of Disease autoimmunity, the antinuclear antibody (ANA) provides information that can be difficult to interpret and, thereby, can contribute to misnaming of certain signs and symptoms as an autoimmune disease, especially systemic lupus erythematosus (SLE). Although a positive ANA test is now considered necess
发表于 2025-3-23 06:32:32 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-11 04:46
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表